Improved Treatment Options for Parkinson’s Disease
Dr. Verhagen discusses options for treating worsening motor fluctuations and dyskinesia.
Katzenschlager R et al. Lancet Neurology. 2018;17:749. Okun MS. NEJM Journal Watch Neurology, 2018. Karl JA et al. Brain Sci. 2018;8:60. Limousin P et al. Nature Reviews Neurol. 2019;15:234-242.
Dr. Verhagen Metman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbott, Medtronic, Boston Scientific, AbbVie. Dr. Verhagen Metman has received research support from Abbott, Medtronic, Boston Scientific, AbbVie, Adamas, Neuroderm, WorldMeds, NIH.